Souders Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52M | Sell |
8,181
-3,509
| -30% | -$651K | 0.19% | 64 |
|
|
2025
Q1 | $2.45M | Sell |
11,690
-5,385
| -32% | -$1.13M | 0.34% | 50 |
|
|
2024
Q4 | $3.03M | Sell |
17,075
-5,265
| -24% | -$936K | 0.42% | 55 |
|
|
2024
Q3 | $4.41M | Buy |
22,340
+416
| +2% | +$82.2K | 0.61% | 45 |
|
|
2024
Q2 | $3.76M | Buy |
21,924
+921
| +4% | +$158K | 0.57% | 45 |
|
|
2024
Q1 | $3.82M | Buy |
21,003
+17,924
| +582% | +$3.26M | 0.6% | 44 |
|
|
2023
Q4 | $477K | Sell |
3,079
-2
| -0.1% | -$310 | 0.08% | 119 |
|
|
2023
Q3 | $459K | Buy |
3,081
+62
| +2% | +$9.24K | 0.09% | 120 |
|
|
2023
Q2 | $407K | Sell |
3,019
-24
| -0.8% | -$3.23K | 0.08% | 124 |
|
|
2023
Q1 | $485K | Sell |
3,043
-104
| -3% | -$16.6K | 0.1% | 114 |
|
|
2022
Q4 | $509K | Buy |
3,147
+40
| +1% | +$6.46K | 0.12% | 111 |
|
|
2022
Q3 | $417K | Buy |
3,107
+55
| +2% | +$7.38K | 0.11% | 116 |
|
|
2022
Q2 | $468K | Buy |
3,052
+392
| +15% | +$60.1K | 0.13% | 104 |
|
|
2022
Q1 | $431K | Buy |
2,660
+30
| +1% | +$4.86K | 0.12% | 109 |
|
|
2021
Q4 | $356K | Sell |
2,630
-29
| -1% | -$3.93K | 0.1% | 111 |
|
|
2021
Q3 | $287K | Buy |
2,659
+175
| +7% | +$18.9K | 0.09% | 115 |
|
|
2021
Q2 | $280K | Buy |
2,484
+2
| +0.1% | +$225 | 0.09% | 113 |
|
|
2021
Q1 | $269K | Buy |
2,482
+13
| +0.5% | +$1.41K | 0.11% | 106 |
|
|
2020
Q4 | $265K | Hold |
2,469
| – | – | 0.12% | 97 |
|
|
2020
Q3 | $244K | Buy |
2,469
+104
| +4% | +$10.3K | 0.12% | 95 |
|
|
2020
Q2 | $232K | Buy |
+2,365
| New | +$232K | 0.13% | 90 |
|